Response to comments on: Retinal vein occlusion in COVID-19: A novel entity
Open Access
- 1 January 2021
- journal article
- letter
- Published by Medknow in Indian Journal of Ophthalmology
- Vol. 69 (1), 195-196
- https://doi.org/10.4103/ijo.ijo_3319_20
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Is a “Cytokine Storm” Relevant to COVID-19?JAMA Internal Medicine, 2020
- The role of biomarkers in diagnosis of COVID-19 – A systematic reviewLife Sciences, 2020
- C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 earlyJournal of Medical Virology, 2020
- Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from Coronavirus Disease 2019 (COVID-19) InfectionAnnals of the Academy of Medicine, Singapore, 2020
- Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control studyInternational Journal of Medical Sciences, 2020
- Intravitreal bevacizumab for postviral fever retinitis: a novel approach for early resolution of macular oedemaBMJ Case Reports, 2018
- Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A ReviewJournal of Ocular Pharmacology and Therapeutics, 2017
- Intravitreal Steroids for the Treatment of Retinal DiseasesThe Scientific World Journal, 2014
- Changes in the Intraocular Cytokine Levels after Intravitreal Bevacizumab in Uveitic Macular EdemaOcular Immunology and Inflammation, 2012
- Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edemaAmerican Journal of Ophthalmology, 2001